Antibiotic resistance: Do we need new therapeutic approaches?

Chest

Volumn 108, Issue 2 SUPPL., 1995, Pages 70S-78S

  Felmingham, D ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACITRACIN; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; NOVOBIOCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLACEAE; LEGIONNAIRE DISEASE; LUNG TUBERCULOSIS; MORAXELLA CATARRHALIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE;

EID: 0029125724     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Kislak JW Razavi LMB Daly AK Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 250 1965 261 268
2. Erikson KR Studies on induced resistance to penicillin in a pneumococcus type 1. Acta Pathol Microbiol Scand 22 1945 398 405
3. Hansman D Bullen MM A resistant pneumococcus. Lancet 2 1967 264 265
4. Appelbaum PC Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15 1992 77 83
5. Appelbaum PC Bhamjee A Scragg JN Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 2 1977 995 997
6. Jacobs MR Koornhof HJ Robins-Browne RM Emergence of multiply-resistant pneumococci. N Engl J Med 299 1978 735 740
7. Klugman KP Pneumococcal resistance to the third-generation cephalosporins: clinical, laboratory and molecular aspects. Int J Antimicrob Agents 4 1994 63 67
8. Klugman KP Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3 1990 171 196
9. Leclercq R Courvalin P Bacterial resistance to macrolide, lineosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 35 1991 1267 1272
10. Linares J Pallares R Alonso T Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 15 1992 99 105
11. Courvalin P Carlier C Transposable multiple antibiotic resistance in Streptococcus pneumoniae . Mol Gen Genet 205 1986 291 297
12. Mathies AW Jr. Penicillins in the treatment of bacterial meningitis. J R Coll Physicians Lond 6 1972 139 146
13. Khan W Ross S Rodriguez W Haemophilus influenzae type B resistant to ampicillin: a report of two cases. JAMA 229 1974 298 301
14. Tomeh MO Starr SE McGowan JE Ampicillin-resistant Haemophilus influenzae type b infection. JAMA 229 1974 295 297
15. Sykes RB Matthews M O’Callaghan CH R-factor mediated beta-lactamase production by Haemophilus influenzae . J Med Microbiol 8 1975 437 441
16. Daum RS Murphey-Corb M Shapira E Epidemiology of Rob β-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis 157 1988 450 455
17. Markowitz SM Isolation of an ampicillin-resistant non-β-lactamase producing strain of Haemophilus influenzae . Antimicrob Agents Chemother 17 1980 80 83
18. Mendelman PM Chaffin DO Stull TL Characterisation of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae . Antimicrob Agents Chemother 26 1984 235 244
19. Jorgensen JH Doern GV Thomsberry C Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents. Diagn Microbiol Infect Dis 9 1988 27 32
20. Doern GV Jorgensen JH Thomsberry C Haemophilus influenzae Surveillance Group: prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis 4 1986 95 107
21. Doern GV Jorgensen JH Thomsberry C National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae . Antimicrob Agents Chemother 32 1988 180 185
22. Jorgensen JH Doern GV Maher LA Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 35 1990 2075 2080
23. Machkla K Braveny L Dabernatt H Distribution and resistance patterns of Haemophilus influenzae a European cooperative study. Eur J Clin Microbiol Infect Dis 7 1988 14 24
24. Powell M Koutsia-Caronzou C Voutsinas D Resistance of clinical isolates of Haemophilus influenzae in the United Kingdom. BMJ 295 1987 176 179
25. Powell M Fah YS Seymour A Antimicrobial resistance in Haemophilus influenzae from England and Scotland 1991. Antimicrob Chemother 29 1992 S47 54
26. Kumana CR Haemophilus influenzae a worldwide pathogen 1987 Science Press Hong Kong
27. Weinberg GA Spitzer ED Murray PR Antimicrobial susceptibility patterns of Haemophilus isolates from children in 11 developing nations. Bull World Health Organ 68 1990 179 184
28. Van Klingeren B van Embden JDA Dessens-Kroon M Plasmid-mediated chloramphenicol resistance in Haemophilus influenzae . Antimicrob Agents Chemother 11 1977 383 387
29. Jorgenson JH Update on mechanisms and prevalence of antimicrobial resistance in H influenzae . Clin Infect Dis 14 1992 1119 1123
30. Kayser FH Morenzoni G Santanam P The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae . Eur J Clin Microbiol Infect Dis 9 1990 810 817
31. Gould IM Forbes KJ Gordon GS Quinolone-resistant Haemophilus influenzae . J Antimicrob Chemother 33 1994 187 188
32. Catlin BN Branhamella catarrhalis an organism gaining respect as a pathogen. Clin Microbiol Rev 3 1990 293 320
33. Berk SL From Micrococcus to Moraxella: the re-emergence of Branhamella catarrhalis . Arch Intern Med 150 1990 2254 2257
34. Jorgensen JH Doern GV Maher LA Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 34 1990 2075 2080
35. 12 gene and point mutations with a functional 16S ribosomal RNA pseudoknot. Mol Micro 9 1993 1239 1246
36. Zhang Y Young D Molecular genetics of drug resistance in Mycobacterium tuberculosis . J Antimicrob Chemother 34 1994 313 319
37. Honore N Cole ST Molecular basis of rifampicin resistance in Mycobacterium leprac . Antimicrob Agents Chemother 37 1993 414 418
38. Telenti A Imboden P Marchesi F Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis . Lancet 341 1993 647 650
39. Konno K Fieldmann FM McDermott W Pyrazinamide susceptibility and anúdase activity of tubercle bacilli. Am Rev Respir Dis 95 1967 461 469
40. Young LS Mycobacterial diseases in the 1990s. J Antimicrob Chemother 32 1993 179 194
41. Bergogne-Bérézin E Decré D Joly-Guillou M-L Opportunistic nosocomial multiply-resistant bacterial infections—their treatment and prevention. J Antimicrob Chemother 32 suppl A 1993 39 47
42. Mariotte S Nordmann P Nicolas MH Extended spectrum β-lactamase in Proteus mirabilis . J Antimicrob Chemother 33 1994 925 935
43. Livermore D Carbapenemases. J Antimicrob Chemother 29 1992 609 616
44. Sirot D Chanal C Henquell C Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to β-lactamase inhibitors. J Antimicrob Chemother 33 1994 1117 1126
45. Brown NM Reeves DS Mechanisms and epidemiology of aminoglycoside resistance. J Med Microbiol 36 1992 11 14
46. Lewin CS Resistance to the 4-quinolones. J Med Microbiol 36 1992 9 11
47. Fukudu H Hosaka M Hirai K New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother 34 1990 1757 1761
48. Chopra J Efflux-based antibiotic resistance mechanisms: the evidence for increasing prevalence. J Antimicrob Chemother 30 1992 737 739
49. De Lencastre H de Jonge BLM Matthews PR Molecular aspects of methicillin resistance in Staphylococcus aureus . J Antimicrob Chemother 33 1994 7 24
50. Felmingham D Towards the ideal glycopeptide. J Antimicrob Chemother 32 1993 663 666
51. Murray BE The life and times of the enterococcus. Clin Microbiol Rev 3 1990 46 65
52. Arthur M Courvalin P Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 37 1993 1563 1571
53. Baselski VS Wunderink RG Bronchoscopic diagnosis of pneumonia. Clin Micro Rev 7 1994 533 558
54. Fluiz AC Visser MR Nucleic acid analysis of antibiotic resistance. Int J Antimicrob Agents 1 1992 205 222
55. Begg NT Immunoprophylaxis at extremes of age. J Antimicrob Chemother 34 suppl A 1994 121 128
56. Pennington JE Immunological perspectives in prevention and treatment of nosocomial pneumonia. Intensive Care Med 18 1992 S35 8
57. Dale DC Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. Clin Infect Dis 18 suppl 2S 1994 180 188
58. Fung CP Yeo SF Livermore DM Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase pattem. J Antimicrob Chemother 33 1994 215 222